The study, which ended early, involved 125 health care workers – some of whom took hydroxychloroquine daily for eight weeks while others took placebo.
Based on their findings, researchers at the University of Pennsylvania wrote that they “cannot recommend the regular use of hydroxychloroquine among health care workers to prevent Kovid-19.”
Participants enrolled in the new study from April to July. It found that four out of 64 health workers who were randomly given hydroxychloroquine tested positive for Kovid-19 and four out of 61 health workers who were tested positive for placebo.
According to the study, of the eight participants who tested positive, six developed symptoms, none required hospitalization and all of them recovered from the disease.
Boulware said he advised Trump’s physician that there had been no published research demonstrating hydroxychloroquine, worked preventively, and shared that those in his study who took hydroxychloroquine had higher rates of side effects Was, mostly gastrointestinal problems such as nausea and vomiting.
“I knew they were probably going to ignore my point because the White House had been talking about hydroxychloroquine for weeks and weeks and weeks,” said Boolware, an infectious disease specialist and professor of medicine at the University of Minnesota.
“Even in the setting of an epidemic, we need research to help inform best practice for what works in humans,” Bowlware said.